medigraphic.com
ISSN 0326-3428 (Impreso)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2020, Número 1

Siguiente >>

Rev Nefrol Dial Traspl 2020; 40 (1)


Salud renal para todos en todas partes – desde la prevención a la detección y al acceso equitativo al tratamiento

Kam-Tao LP, Garcia-Garcia G, Siu-Fai L, Sharon AL, Wing-Shing FW, Hradsky A, Kumaraswami L, Liakopoulos V, Rakhimova Z, Saadi G, Strani L, Ulasi I, Kalantar-Zadeh K

Idioma: Ingles.
Referencias bibliográficas: 56
Paginas: 1-13
Archivo PDF: 433.66 Kb.


FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. International Society of Nephrology. United NationsHight Level Meeting on Universal Health Coverage.Moving together to build Kidney Health Worldwide[Internet]. ISN, 2019. Disponible en: https://www.theisn.org/images/Advocacy_4_pager_2019_Final_WEB_pagebypage.pdf (Consulta: 20/07/2019).

  2. Foreman KJ, Marquez N, Dolgert A, Fukutaki K,Fullman N, McGaughey M, et al. Forecasting lifeexpectancy, years of life lost, and all-cause and causespecificmortality for 250 causes of death: reference andalternative scenarios for 2016-40 for 195 countries andterritories. Lancet. 2018;392(10159):2052-90.

  3. Essue BM, Laba T, Knaul F, Chu A, Van Minh H,Phuong Nguyen TH, et al. Economic burden of chronicill health and injuries for households in low- and middleincomecountries. In: Jamison DT, Gelband H, HortonS, Jha P, Laxminarayan R, Mock CN, et al., eds. Diseasecontrol priorities: improving health and reducing poverty.3rd ed. Washington, DC: World Bank, 2018, p. 121-43.

  4. Luyckx VA, Tuttle KR, Garcia-Garcia G, Gharbi MB,Heerspink HJL, Johnson DW, et al. Reducing majorrisk factors for chronic kidney disease. Kidney Int Suppl.2017;7(2):71-87.

  5. Luyckx VA, Tonelli M, Stanifer JW. The global burdenof kidney disease and the sustainable developmentgoals. Bull World Health Organ. 2018; 96(6):414-22D.

  6. Tonelli M, Muntner P, Lloyd A, Manns BJ, KlarenbachS, Pannu N, et al. Risk of coronary events in peoplewith chronic kidney disease compared with thosewith diabetes: a population-level cohort study. Lancet.2012;380(9844): 807-14.

  7. Kalantar-Zadeh K, Fouque D. Nutritionalmanagement of chronic kidney disease. N Engl J Med.2017;377(18):1765-76.

  8. United Nations General Assembly. Political declarationof the third high-level meeting of the General Assemblyon the prevention and control of non-communicablediseases [Internet]. Oct. 2018. Dsiponible en: https://www.un.org/ga/search/view_doc.asp?symbol=A/73/L.2&Lang=E (Consulta: 20/07/2019).

  9. López AD, Williams TN, Levin A, Tonelli M, SinghJA, Burney PG, et al. Remembering the forgottennon-communicable diseases. BMC Med. 2014;12:200.

  10. Estados Unidos. Centers for Disease Control andPrevention. Picture of America [Internet]. WashingtonDC: CDC, 2019. Disponible en: https://www.cdc.gov/pictureofamerica/index.html (Consulta: 20/07/2019).

  11. Levey AS, Schoolwerth AC, Burrows NR, Williams DE,Stith KR, McClellan W. Comprehensive public healthstrategies for preventing the development, progression,and complications of CKD: report of an expert panelconvened by the Centers for Disease Control andPrevention. Am J Kidney Dis. 2009;53(3):522-35.

  12. Saran R, Robinson B, Abbott KC, Agodoa LYC,Bragg-Gresham J, Balkrishnan R, et al. US Renal DataSystem 2018 Annual Data Report: Epidemiology ofKidney Disease in the United States. Am J Kidney Dis.2019;73(3S1):A7-A8.

  13. Kovesdy CP, Furth SL, Zoccali C; World KidneyDay Steering Committee. Obesity and kidney disease:hidden consequences of the epidemic. J Ren Nutr.2017;27(2):75-7.

  14. Tantisattamo E, Dafoe DC, Reddy UG, Ichii H, RheeCM, Streja E, et al. Current management of acquiredsolitary kidney. Kidney Int Rep. 2019;4(9):1205-18.

  15. Webster AC, Nagler EV, Morton RL, Masson P. Chronickidney disease. Lancet. 2017;389(10075):1238-52.

  16. Koppe L, Fouque D. The role for protein restrictionin addition to renin-angiotensin-aldosterone systeminhibitors in the management of CKD. Am J KidneyDis. 2019;73(2):248-57.

  17. Rifkin DE, Coca SG, Kalantar-Zadeh K. Does AKItruly lead to CKD? J Am Soc Nephrol. 2012; 23(6):979-84.

  18. 18) Torres VE, Chapman AB, Devuyst O, GansevoortRT, Grantham JJ, Higashihara E, et al. Tolvaptan inpatients with autosomal dominant polycystic kidneydisease. N Engl J Med. 2012;367(25):2407-18.

  19. Verhave JC, Troyanov S, Mongeau F, Fradette L,Bouchard J, Awadalla P, et al. Prevalence, awareness,and management of CKD and cardiovascular riskfactors in publicly funded health care. Clin J Am SocNephrol. 2014;9(4):713-9.

  20. Chow KM, Szeto CC, Kwan B, Leung CB, Li PK.Public lacks knowledge on chronic kidney disease:telephone survey. Hong Kong Med J. 2014;20(2):139-44.

  21. Ene-Iordache B, Perico N, Bikbov B, Carminati S,Remuzzi A, Perna A, et al. Chronic kidney diseaseand cardiovascular risk in six regions of the world(ISN-KDDC): a cross-sectional study. Lancet GlobHealth. 2016;4(5):e307-19.

  22. Li PK, Weening JJ, Dirks J, Lui SL, Szeto CC, TangS, et al. A report with consensus statements of theInternational Society of Nephrology 2004 ConsensusWorkshop on Prevention of Progression of RenalDisease, Hong Kong, June 29, 2004. Kidney Int Suppl.2005;(94):S2-7.

  23. Vassalotti JA, Stevens LA, Levey AS. Testing forchronic kidney disease: a position statement fromthe National Kidney Foundation. Am J Kidney Dis.2007;50(2):169-80.

  24. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ,Eckardt KU, et al. Chronic kidney disease as a globalpublic health problem: approaches and initiatives - aposition statement from Kidney Disease ImprovingGlobal Outcomes. Kidney Int. 2007;72(3):247-59.

  25. Crowe E, Halpin D, Stevens P; Guideline DevelopmentGroup. Early identification and management of chronickidney disease: summary of NICE guidance. BMJ.2008;337:a1530.

  26. Li PK, Chow KM, Matsuo S, Yang CW, Jha V, BeckerG, et al. Asian chronic kidney disease best practicerecommendations: positional statements for earlydetection of chronic kidney disease from Asian Forumfor Chronic Kidney Disease Initiatives (AFCKDI).Nephrology (Carlton). 2011;16(7):633-41.

  27. Fink HA, Ishani A, Taylor BC, Greer NL, MacDonaldR, Rossini D, et al. Screening for, monitoring, andtreatment of chronic kidney disease stages 1 to 3: asystematic review for the U.S. Preventive Services TaskForce and for an American College of Physicians ClinicalPractice Guideline. Ann Intern Med. 2012;156(8):570-81.

  28. Li PK, Ng JK, Cheng YL, Kwan TH, Leung CB, LauMF, et al. Relatives in silent kidney disease screening(RISKS) study: A Chinese cohort study. Nephrology(Carlton). 2017;22(Suppl. 4):35-42.

  29. Samal L, Linder JA. The primary care perspective onroutine urine dipstick screening to identify patients withalbuminuria. Clin J Am Soc Nephrol. 2013;8(1):131-5.

  30. George C, Mogueo A, Okpechi I, Echouffo-TcheuguiJB, Kengne AP. Chronic kidney disease in low-incometo middle-income countries: the case for increasedscreening. BMJ Glob Health. 2017;2(2):e000256.

  31. Gonzalez-Quiroz M, Nitsch D, Hamilton S,O’Callaghan Gordo C, Saran R, Glaser J, et al. Rationaleand population-based prospective cohort protocol forthe disadvantaged populations at risk of decline ineGFR (CO-DEGREE). BMJ Open. 2019;9(9):e031169.

  32. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL,Powe NR. Screening for proteinuria in US adults: a costeffectivenessanalysis. JAMA. 2003;290(23):3101-14.

  33. Go DS, Kim SH, Park J, Ryu DR, Lee HJ, Jo MW.Cost-utility analysis of the National Health ScreeningProgram for chronic kidney disease in Korea. Nephrology(Carlton). 2019;24(1):56-64.

  34. Komenda P, Ferguson TW, Macdonald K, RigattoC, Koolage C, Sood MM, et al. Cost-effectiveness ofprimary screening for CKD: a systematic review. Am JKidney Dis. 2014;63(5):789-97.

  35. 35) Hwang SJ, Tsai JC, Chen HC. Epidemiology, impactand preventive care of chronic kidney disease in Taiwan.Nephrology (Carlton). 2010;15(Suppl. 2):3-9.

  36. Almaguer M, Herrera R, Alfonso J, Magrans C,Mañalich R, Martínez A. Primary health care strategiesfor the prevention of end-stage renal disease in Cuba.Kidney Int. 2005;68( 97):S4-10.

  37. Alamaguer-López M, Herrera-Valdez R, Díaz J,Rodríguez O. Integration of chronic kidney diseaseprevention into noncommunicable disease programsin Cuba. En: G. Garcia-Garcia, LY Agodoa, KCNorris (eds.). Chronic kidney disease in disadvantagedpopulation. London: Elsevier, 2017, pp. 357-65.

  38. Estados Unidos. Department of Health and HumanServices. Advancing american kidney health [Internet].Disponible en: https://aspe.hhs.gov/system/files/pdf/262046/AdvancingAmericanKidneyHealth.pdf(Consulta: 20/07/2019).

  39. Estados Unidos. Department of Health and HumanServices, Office of the Assistant Secretary for Planningand Evaluation. The Special Diabetes Program forIndians. Estimates of Medicare savings [Internet]. ASPEIssue Brief, may 10 2019. Disponible en: https://aspe.hhs.gov/system/files/pdf/261741/SDPI_Paper_Final.pdf (Consulta: 26/09/2019).

  40. Bello AK, Nwankwo E, El Nahas AM. Prevention ofchronic kidney disease: a global challenge. Kidney IntSuppl. 2005;(98):S11-7.

  41. James MT, Hemmelgarn BR, Tonelli M. Earlyrecognition and prevention of chronic kidney disease.Lancet. 2010; 375(9722):1296-309.

  42. Cortés-Sanabria L, Cabrera-Pivaral CE, Cueto-Manzano AM, Rojas-Campos E, Barragán G,Hernández-Anaya M, et al. Improving care of patientswith diabetes and CKD: a pilot study for a clusterrandomizedtrial. Am J Kidney Dis. 2008;51(5):777-88.

  43. Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G,et al. Renal function preservation in type 2 diabetesmellitus patients with early nephropathy: a comparativeprospective cohort study between primary healthcare doctors and a nephrologist. Am J Kidney Dis.2006;47(1):78-87.

  44. Cueto-Manzano AM, Martínez-Ramírez HR, Cortes-Sanabria L, Rojas-Campos E. CKD screening andprevention strategies in disadvantaged populations. Therole of primary health care professionals. En: G. Garcia-Garcia, LY Agodoa, KC Norris (eds.). Chronic kidneydisease in disadvantaged population. London: Elsevier,2017, pp. 329-35.

  45. Tapia-Conyer R, Gallardo-Rincon H, Betancourt-Cravioto M. Chronic kidney disease in disadvantagedpopulations: Online educational programs for NCDprevention and treatment. En: G. Garcia-Garcia, LYAgodoa, KC Norris (eds.). Chronic kidney disease indisadvantaged population. London: Elsevier, 2017, pp.337-45.

  46. Bello AK, Levin A, Manns BJ, Feehally J, DruekeT, Faruque L, et al. Kidney Health for Life Initiative.Effective CKD care in european countries: challengesand opportunities for health policy. Am J Kidney Dis.2015;65(1):15-25.

  47. Sharif MU, Elsayed M E, Stack AG. The globalnephrology workforce: emerging threats and potentialsolutions. Clin Kidney J. 2016;9(1):11-22.Recibido en su forma original: 8 de noviembre de 2019Aceptación final: 15 de noviembre de 2019Dr. Philip Kam-Tao LiDepartment of Medicine and Therapeutics, Carol & Richard Yu PD Research Centre,Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, Chinae-mail: philipli@cuhk.edu.hk

  48. Naicker S, Eastwood JB, Plange-Rhule J, Tutt RC.Shortage of healthcare workers in sub-Saharan Africa: anephrological perspective. Clin Nephrol. 2010;74(Suppl1):S129-33.

  49. Cusumano AM, Rosa-Diez GJ, González-Bedat MC.Latin American Dialysis and Transplant Registry:Experience and contributions to end-stage renal diseaseepidemiology. World J Nephrol. 2016;5(5):389-97.

  50. Feehally J, Brusselmans A, Finkelstein FO, Harden P,Harris D, Manuzi G, et al. Improving global health:measuring the success of capacity building outreachprograms: a view from the International Society ofNephrology. Kidney Int Suppl. 2016; 6(2): 42-51.

  51. Harris DC, Dupuis S, Couser WG, Feehally J. Trainingnephrologists from developing countries: does it have apositive impact? Kidney Int Suppl. 2012;2(3):275-8.

  52. Morbidity and mortality of renal dialysis: anNIH consensus conference statement. ConsensusDevelopment Conference Panel. Ann Intern Med.1994;121(1): 62-70.

  53. García-García G, Martínez-Castellanos Y, Renoirte-Lopez K, Barajas-Murguia A, de la Torre-Campos L,Becerra-Muñóz LE, et al. Multidisciplinary care forpoor patients with chronic kidney disease in Mexico.Kidney Int Suppl. 2013;3(2):178-83.

  54. Stanifer JW, Von Isenburg M, Chertow GM, Anand S.Chronic kidney disease care models in low- and middleincomecountries: a systematic review. BMJ Glob Health.2018;3(2):e000728.

  55. Narva AS, Norton JM, Boulware LE. Educatingpatients about CKD: the path to self-managementand patient-centered care. Clin J Am Soc Nephrol.2016;11(4):694-703.

  56. Schatell D. Web-based kidney education: supportingpatient self-management. Semin Dial. 2013;26(2):154-8.




2020     |     www.medigraphic.com